← Back to Pfizer Ltd. overview
Pfizer Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹2,281 cr | ₹768 cr | ₹167.79 | ₹4,911 cr | ₹4,217 cr | 18.2% | 23.68% | 0.03x | 33.65% |
| FY2024 | ₹2,193 cr | ₹551 cr | ₹120.51 | ₹4,229 cr | ₹3,596 cr | 15.33% | 20.64% | 0.03x | 25.14% |
| FY2023 | ₹2,422 cr | ₹624 cr | ₹136.38 | ₹4,001 cr | ₹3,207 cr | 19.45% | 25.06% | 0.04x | 25.76% |
| FY2022 | ₹2,611 cr | ₹613 cr | ₹133.89 | ₹3,901 cr | ₹2,864 cr | 21.39% | 25.84% | 0.06x | 23.46% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.